Gene therapy hearing
Executive Summary
Senate HELP/Public Health Subcommittee Chair Bill Frist (R-Tenn.) plans to hold a gene therapy oversight hearing Jan. 26. Although the witness list has not been finalized, it is expected to include representatives from the National Institutes of Health and FDA. Frist has been looking into the deaths of patients in gene therapy trials (1"The Pink Sheet" Dec. 6, 1999, p. 13)